Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 68.61%
March 31, 2026 66.56%
December 31, 2025 67.34%
September 30, 2025 67.75%
June 30, 2025 69.84%
March 31, 2025 69.84%
December 31, 2024 69.75%
September 30, 2024 70.74%
June 30, 2024 67.31%
March 31, 2024 71.94%
December 31, 2023 66.73%
September 30, 2023 68.44%
June 30, 2023 66.35%
March 31, 2023 72.35%
December 31, 2022 67.34%
September 30, 2022 71.71%
June 30, 2022 72.58%
March 31, 2022 67.97%
December 31, 2021 53.85%
September 30, 2021 54.30%
June 30, 2021 74.71%
March 31, 2021 73.41%
September 30, 2020 73.20%
June 30, 2020 67.86%
March 31, 2020 71.22%
Date Value
December 31, 2019 72.74%
September 30, 2019 67.80%
June 30, 2019 71.15%
March 31, 2019 71.32%
December 31, 2018 74.99%
September 30, 2018 66.44%
June 30, 2018 72.75%
March 31, 2018 74.64%
December 31, 2017 75.62%
September 30, 2017 71.63%
June 30, 2017 73.68%
March 31, 2017 73.89%
December 31, 2016 75.06%
September 30, 2016 73.43%
June 30, 2016 73.11%
March 31, 2016 74.28%
December 31, 2015 72.09%
September 30, 2015 70.10%
June 30, 2015 66.10%
March 31, 2015 67.89%
December 31, 2014 66.68%
September 30, 2014 58.81%
June 30, 2014 64.67%
March 31, 2014 61.01%
December 31, 2013 58.61%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Kao Corp. 39.51%
Kosé Holdings Corp. 69.91%
Milbon Co. Ltd. 64.05%
Rohto Pharmaceutical Co., Ltd. 55.72%
Mandom Corp. 47.80%